2025 연구자 정보 (126 / 654)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Park, Ki Nam
(Park, KN) ⓘ 		Soonchunhyang Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Bucheon, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 5.2%] Guidelines for the Treatment of Laryngeal Cancer from the Korean Society of Head and Neck Surgery ⓘ SCIE ⓘ 5.2 OTORHINOLARYNGOLOGY ⓘ junook2000@catholic.ac.kr
entckj@catholic.ac.kr ⓘ
Park, Sung Joon
(Park, SJ) ⓘ 		Chung Ang Univ, Gwangmyeong Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea ⓘ MTF-3122-2025
Park, Sung Joon ⓘ
ⓘ 		[JCR상위 5.2%] Guidelines for the Treatment of Laryngeal Cancer from the Korean Society of Head and Neck Surgery
[JCR상위 1.7%] Predicting high-risk group according to Oncotype DX recurrence score using dynamic contrast-enhanced breast MR with temporal radiomic features. ⓘ 		SCIE ⓘ 1.7 OTORHINOLARYNGOLOGY
ONCOLOGY ⓘ 		junook2000@catholic.ac.kr
entckj@catholic.ac.kr ⓘ
Polizzi, Karen M.
(Polizzi, KM) ⓘ 		Imperial Coll London, Dept Chem Engn, London, England
Imperial Coll London, Imperial Coll Ctr Synthet Biol, London, England ⓘ
ⓘ 		0000-0001-5435-2667
Polizzi, Karen ⓘ 		[JCR상위 5.2%] Manipulating subcellular protein localization to enhance target protein accumulation in minicells ⓘ SCIE ⓘ 5.2 BIOCHEMICAL RESEARCH METHODS
BIOTECHNOLOGY & APPLIED MICROBIOLOGY ⓘ 		juhyunkim@knu.ac.kr ⓘ
Ryu, Yoon-Jong
(Ryu, YJ) ⓘ 		Kangwon Natl Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Chuncheon, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 5.2%] Guidelines for the Treatment of Laryngeal Cancer from the Korean Society of Head and Neck Surgery ⓘ SCIE ⓘ 5.2 OTORHINOLARYNGOLOGY ⓘ junook2000@catholic.ac.kr
entckj@catholic.ac.kr ⓘ
Seok, Jungirl
(Seok, J) ⓘ 		Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 5.2%] Guidelines for the Treatment of Laryngeal Cancer from the Korean Society of Head and Neck Surgery ⓘ SCIE ⓘ 5.2 OTORHINOLARYNGOLOGY ⓘ junook2000@catholic.ac.kr
entckj@catholic.ac.kr ⓘ
Shin, Sung-Chan
(Shin, SC) ⓘ 		Pusan Natl Univ, Pusan Natl Univ Hosp, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Busan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 5.2%] Guidelines for the Treatment of Laryngeal Cancer from the Korean Society of Head and Neck Surgery ⓘ SCIE ⓘ 5.2 OTORHINOLARYNGOLOGY ⓘ junook2000@catholic.ac.kr
entckj@catholic.ac.kr ⓘ
Song, Chang Myeon
(Song, CM) ⓘ 		Hanyang Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea ⓘ W-1761-2017
Song, Chang Myeon ⓘ
ⓘ 		[JCR상위 5.2%] Guidelines for the Treatment of Laryngeal Cancer from the Korean Society of Head and Neck Surgery ⓘ SCIE ⓘ 5.2 OTORHINOLARYNGOLOGY ⓘ junook2000@catholic.ac.kr
entckj@catholic.ac.kr ⓘ
Won, Ho-Ryun
(Won, HR) ⓘ 		Chungnam Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Daejeon, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 5.2%] Guidelines for the Treatment of Laryngeal Cancer from the Korean Society of Head and Neck Surgery ⓘ SCIE ⓘ 5.2 OTORHINOLARYNGOLOGY ⓘ junook2000@catholic.ac.kr
entckj@catholic.ac.kr ⓘ
Baek, Nam-In
(Baek, NI) ⓘ 		Kyung Hee Univ, Grad Sch Biotechnol, Yongin 17104, South Korea
Kyung Hee Univ, Dept Oriental Med Biotechnol, Yongin 17104, South Korea ⓘ 		AAK-7447-2020
Baek, Nam-In ⓘ
ⓘ 		[JCR상위 5.3%] The inhibition of endothelial DLL4-NOTCH1 signaling by 2'-hydroxyflavanone enhances anti-PD-1 therapy in melanoma ⓘ SCIE ⓘ 5.3 CHEMISTRY, MEDICINAL
PHARMACOLOGY & PHARMACY ⓘ 		lym@knu.ac.kr ⓘ
Ha, Seunghwan
(Ha, S) ⓘ 		Kyungpook Natl Univ, Coll Pharm, Vessel Organ Interact Res Ctr, VOICE MRC, 80 Daehak Ro, Daegu 41566, South Korea
Kyungpook Natl Univ, Coll Pharm & Res Inst Pharmaceut Sci, BK21 FOUR Community Based Intelligent Novel Drug D, Daegu 41566, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 5.3%] The inhibition of endothelial DLL4-NOTCH1 signaling by 2'-hydroxyflavanone enhances anti-PD-1 therapy in melanoma ⓘ SCIE ⓘ 5.3 CHEMISTRY, MEDICINAL
PHARMACOLOGY & PHARMACY ⓘ 		lym@knu.ac.kr ⓘ
Jeong, Ji-Hak
(Jeong, JH) ⓘ 		Kyungpook Natl Univ, Coll Pharm, Vessel Organ Interact Res Ctr, VOICE MRC, 80 Daehak Ro, Daegu 41566, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 5.3%] The inhibition of endothelial DLL4-NOTCH1 signaling by 2'-hydroxyflavanone enhances anti-PD-1 therapy in melanoma ⓘ SCIE ⓘ 5.3 CHEMISTRY, MEDICINAL
PHARMACOLOGY & PHARMACY ⓘ 		lym@knu.ac.kr ⓘ
Jung, Jong Hwa
(Jung, JH) ⓘ 		Kyungpook Natl Univ, Coll Pharm, Vessel Organ Interact Res Ctr, VOICE MRC, 80 Daehak Ro, Daegu 41566, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 5.3%] The inhibition of endothelial DLL4-NOTCH1 signaling by 2'-hydroxyflavanone enhances anti-PD-1 therapy in melanoma ⓘ SCIE ⓘ 5.3 CHEMISTRY, MEDICINAL
PHARMACOLOGY & PHARMACY ⓘ 		lym@knu.ac.kr ⓘ
Kim, Doyoung
(Kim, D) ⓘ 		Kyungpook Natl Univ, Coll Pharm, Vessel Organ Interact Res Ctr, VOICE MRC, 80 Daehak Ro, Daegu 41566, South Korea
Kyungpook Natl Univ, Coll Pharm & Res Inst Pharmaceut Sci, BK21 FOUR Community Based Intelligent Novel Drug D, Daegu 41566, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 5.3%] The inhibition of endothelial DLL4-NOTCH1 signaling by 2'-hydroxyflavanone enhances anti-PD-1 therapy in melanoma ⓘ SCIE ⓘ 5.3 CHEMISTRY, MEDICINAL
PHARMACOLOGY & PHARMACY ⓘ 		lym@knu.ac.kr ⓘ
Kim, Hyoung-Geun
(Kim, HG) ⓘ 		Kyung Hee Univ, Grad Sch Biotechnol, Yongin 17104, South Korea
Kyung Hee Univ, Dept Oriental Med Biotechnol, Yongin 17104, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 5.3%] The inhibition of endothelial DLL4-NOTCH1 signaling by 2'-hydroxyflavanone enhances anti-PD-1 therapy in melanoma ⓘ SCIE ⓘ 5.3 CHEMISTRY, MEDICINAL
PHARMACOLOGY & PHARMACY ⓘ 		lym@knu.ac.kr ⓘ
Kim, Se Ha
(Kim, SH) ⓘ 		Kyungpook Natl Univ, Coll Pharm, Vessel Organ Interact Res Ctr, VOICE MRC, 80 Daehak Ro, Daegu 41566, South Korea
Kyungpook Natl Univ, Coll Pharm & Res Inst Pharmaceut Sci, BK21 FOUR Community Based Intelligent Novel Drug D, Daegu 41566, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 5.3%] The inhibition of endothelial DLL4-NOTCH1 signaling by 2'-hydroxyflavanone enhances anti-PD-1 therapy in melanoma ⓘ SCIE ⓘ 5.3 CHEMISTRY, MEDICINAL
PHARMACOLOGY & PHARMACY ⓘ 		lym@knu.ac.kr ⓘ
페이지 이동: